Chiesi Nordic
Gerrit Pallin Lorier is an experienced healthcare professional with a diverse background in the pharmaceutical industry and emergency medical services. Currently serving as Distriktssjef and Health representative hybrid at Pfizer since May 2023, specializing in areas such as migraine, COVID, and cardiovascular health, Gerrit previously held the position of Key Account Manager at Chiesi Nordic, focusing on COPD and asthma management. Prior roles include Regional Territory Manager at Novartis with responsibilities in lung and cardiovascular therapies, as well as Regional Key Account Manager at Takeda Pharmaceuticals. Gerrit has also worked as an ambulance worker and has significant experience in pharmaceutical sales and consultation. Educationally, Gerrit holds a Bachelor's degree in nursing from Sør-Trøndelag University College, alongside various qualifications in emergency medical services and general studies.
This person is not in any offices
Chiesi Nordic
1 followers
Chiesi is an international, privately-owned pharmaceutical company with its Corporate Head Office based in Parma, Italy. Chiesi is dedicated to the research, development and sales of innovative, therapeutic prescription medicines in the fields of respiratory, neonatology, transplant medicine and rare diseases. Founded in 1935, as a family firm, today, Chiesi spans the globe, employing more than 5000 people in 26 affiliates worldwide and distributes its products in more than 70 countries. In the Nordics, Chiesi Pharma AB employs more than 50 dedicated employees, who are based out of our head office in Central Stockholm, the recently integrated Research and Development Centre at Lidingö outside Stockholm or are part of our experienced field-based sales teams. As with every part of the Chiesi group, we embrace a shared set of values and a common code of ethical conduct. This demands the highest standards of reliability, transparency, and individual accountability in everything we do. It emphasizes the importance of collaborative working, putting people first and exchanging knowledge. Implicit in all of these values is a responsible attitude to the social and environmental impact of our actions. Chiesi is entering important new therapy areas, such as organ transplantation and rare diseases, alongside our treatments for respiratory conditions.